Treatment of Chronic Laryngitis With Amitriptyline
Status:
Terminated
Trial end date:
2021-01-15
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled trial will compare the effectiveness of
amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
American Laryngological Association
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination